Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase
| Ano de defesa: | 2021 |
|---|---|
| Autor(a) principal: | |
| Orientador(a): | |
| Banca de defesa: | , , , |
| Tipo de documento: | Tese |
| Tipo de acesso: | Acesso aberto |
| Idioma: | por |
| Instituição de defesa: |
Universidade Federal de Alfenas
|
| Programa de Pós-Graduação: |
Programa de Pós-Graduação em Ciências Farmacêuticas
|
| Departamento: |
Faculdade de Ciências Farmacêuticas
|
| País: |
Brasil
|
| Palavras-chave em Português: | |
| Área do conhecimento CNPq: | |
| Link de acesso: | https://repositorio.unifal-mg.edu.br/handle/123456789/1789 |
Resumo: | Introduction: Psoriasis is an autoimmune, inflammatory and chronic skin disease in which there is an acceleration of cell growth and proliferation, resulting in erythema and ill-defined lesions, with white and red stains and peeling of the epidermis. Methotrexate (MTX) is one of the drugs for the treatment of systemic use, but there are several side effects. Topical administration may be a strategy to vectorize the release of this drug at the site of action, but as the stratum corneum epidermis is a permeation barrier for hydrophilic drugs, it is necessary to develop vehicles that promote its penetration into the skin. Objective: To evaluate the topical effect of MTX in psoriasis using liquid- crystalline systems (CLs) and hydrogels as vehicles. Method: Study of phase behavior by constructing the ternary phase diagram combining polysorbate 80 (Tween® 80), isopropyl myristate (MIP) and MiliQ water to obtain CLs. The hydrogels tested were based on chitosan (HQS), hydroxypropylmethylcellulose phthalate (HHPMC) and alkylated carbomer (HCA). The samples were characterized by polarized light microscopy (MLP), oscillatory rheology, texture analysis (TPA), solubility of MTX, obtaining the release profile, ex vivo bioadhesion studies and in vivo tests in mice with induction of psoriatic dermatitis. Results: Systems containing surfactant / oil / water in the proportions 60/10/30 and 60/20/20 were characterized as lamellar phases (L1 and L2, respectively) and 50/10/40 and 50/20/30 as hexagonal phases ( H1 and H2, respectively). It was possible to solubilize MTX at a concentration of 2 mg / mL in the CLs and in the HCA hydrogel (pH = 7.4), and 0.1 mg / mL in the HQS hydrogel (pH = 3.5) and not solubilized in HPMCP ( pH = 4.5). Oscillatory rheology showed that hexagonal phases are more elastic than lamellar phases, and HCA with behavior similar to lamellar phases. The TPA test correlated with rheology, but ex vivo bioadhesion showed a better interaction of HCA with swine skin in relation to CLs. The release profile showed that H1 and H2 retained MTX more than L1 and L2, due to their more rigid and organized structure. HCA released more MTX showing that the gelled polymer network retains the drug less. The release profile adjusted for the Weibull mathematical model indicated that the release kinetics is fast and complex. As a proof of principle, in vivo tests showed that CLs promoted a more exacerbated inflammatory effect, but the HCA hydrogel had similar efficacy to dexamethasone. Conclusion: Although studies are still needed to understand the toxicity and safety of the systems, in in vivo tests in mice with imiquimod-induced psoriatic dermatitis, topical application of MTX may be a new approach for the treatment of psoriasis with less side effects and proven efficacy. |
| id |
UNIFAL_eab2331aaa6313bd081831721600f6c7 |
|---|---|
| oai_identifier_str |
oai:repositorio.unifal-mg.edu.br:123456789/1789 |
| network_acronym_str |
UNIFAL |
| network_name_str |
Repositório Institucional da Universidade Federal de Alfenas - RiUnifal |
| repository_id_str |
|
| spelling |
Bernardes, Maria Tereza Carneiro Paschoalhttp://lattes.cnpq.br/3119063906096827Novaes, Rômulo DiasSantos, Bruno Da Fonseca DosSantos, Aline Martins DosNeves, Juliana Dos SantosTrevisan , Marcello GarciaCarvalho, Flávia Chivahttp://lattes.cnpq.br/42082661731008262021-03-31T18:05:03Z2021-02-22BERNARDES, Maria Tereza Carneiro Paschoal. Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase. 2021. 126 f. Tese ( Doutorado em Ciências Farmacêuticas) - Universidade Federal de Alfenas, Alfenas, MG, 2021.https://repositorio.unifal-mg.edu.br/handle/123456789/1789Introduction: Psoriasis is an autoimmune, inflammatory and chronic skin disease in which there is an acceleration of cell growth and proliferation, resulting in erythema and ill-defined lesions, with white and red stains and peeling of the epidermis. Methotrexate (MTX) is one of the drugs for the treatment of systemic use, but there are several side effects. Topical administration may be a strategy to vectorize the release of this drug at the site of action, but as the stratum corneum epidermis is a permeation barrier for hydrophilic drugs, it is necessary to develop vehicles that promote its penetration into the skin. Objective: To evaluate the topical effect of MTX in psoriasis using liquid- crystalline systems (CLs) and hydrogels as vehicles. Method: Study of phase behavior by constructing the ternary phase diagram combining polysorbate 80 (Tween® 80), isopropyl myristate (MIP) and MiliQ water to obtain CLs. The hydrogels tested were based on chitosan (HQS), hydroxypropylmethylcellulose phthalate (HHPMC) and alkylated carbomer (HCA). The samples were characterized by polarized light microscopy (MLP), oscillatory rheology, texture analysis (TPA), solubility of MTX, obtaining the release profile, ex vivo bioadhesion studies and in vivo tests in mice with induction of psoriatic dermatitis. Results: Systems containing surfactant / oil / water in the proportions 60/10/30 and 60/20/20 were characterized as lamellar phases (L1 and L2, respectively) and 50/10/40 and 50/20/30 as hexagonal phases ( H1 and H2, respectively). It was possible to solubilize MTX at a concentration of 2 mg / mL in the CLs and in the HCA hydrogel (pH = 7.4), and 0.1 mg / mL in the HQS hydrogel (pH = 3.5) and not solubilized in HPMCP ( pH = 4.5). Oscillatory rheology showed that hexagonal phases are more elastic than lamellar phases, and HCA with behavior similar to lamellar phases. The TPA test correlated with rheology, but ex vivo bioadhesion showed a better interaction of HCA with swine skin in relation to CLs. The release profile showed that H1 and H2 retained MTX more than L1 and L2, due to their more rigid and organized structure. HCA released more MTX showing that the gelled polymer network retains the drug less. The release profile adjusted for the Weibull mathematical model indicated that the release kinetics is fast and complex. As a proof of principle, in vivo tests showed that CLs promoted a more exacerbated inflammatory effect, but the HCA hydrogel had similar efficacy to dexamethasone. Conclusion: Although studies are still needed to understand the toxicity and safety of the systems, in in vivo tests in mice with imiquimod-induced psoriatic dermatitis, topical application of MTX may be a new approach for the treatment of psoriasis with less side effects and proven efficacy.Introdução: A psoríase é uma doença autoimune, inflamatória e crônica de pele em que há uma aceleração do crescimento e proliferação celular, resultando em eritemas e lesões de formato mal definidos, com colorações brancas e vermelhas e descamação da epiderme. O metotrexato (MTX) é um dos fármacos para o tratamento de uso sistêmico, mas há diversos efeitos colaterais. A administração tópica pode ser uma estratégia para vetorizar a liberação deste fármaco no local de ação, mas como o estrato córneo epidérmico é uma barreira de permeação de fármacos hidrofílicos, é necessário o desenvolvimento de veículos que promovam sua penetração na pele. Objetivo: Avaliar o efeito tópico do MTX na psoríase empregando como veículos sistemas líquido- cristalinos (CLs) e hidrogéis. Método: Estudo do comportamento de fases pela construção do diagrama ternário de fases combinando polissorbato 80 (Tween ® 80), miristato de isopropila (MIP) e água MiliQ para obtenção de CLs. Os hidrogéis testados foram baseados em quitosana (HQS), ftalato de hidroxipropilmetilcelulose (HHPMC) e carbômero alquilado (HCA). As amostras foram caracterizadas por microscopia de luz polarizada (MLP), reologia oscilatória, análise de textura (TPA), solubilidade do MTX, obtenção do perfil de liberação, estudos ex vivo de bioadesão e ensaios in vivo em camundongos com indução da dermatite psoriática. Resultados: Sistemas contendo tensoativo/óleo/água nas proporções 60/10/30 e 60/20/20 foram caracterizados como fases lamelares (L1 e L2, respectivamente) e 50/10/40 e 50/20/30 como fases hexagonais (H1 e H2, respectivamente). Foi possível solubilizar o MTX na concentração de 2 mg/mL nos CLs e no hidrogel de HCA (pH=7,4), e 0,1 mg/mL no hidrogel HQS (pH=3,5) e não solubilizado em HPMCP (pH=4,5). A reologia oscilatória mostrou que fases hexagonais são mais elásticas que as lamelares, e HCA com comportamento semelhante às lamelares. O teste de TPA correlacionou com a reologia, porém a bioadesão ex vivo mostrou melhor interação de HCA com a pele suína em relação aos CLs. O perfil de liberação mostrou que H1 e H2 retiveram mais o MTX que L1 e L2, devido a sua estrutura mais rígida e organizada. HCA liberou mais MTX mostrando que a rede polimérica gelificada retém menos o fármaco.O perfil de liberação ajustado para o modelo matemático de Weibull indicou que a cinética de liberação é rápida e complexa. Como prova de princípio, os testes in vivo demonstraram que os CLs promoveram um efeito inflamatório mais exacerbado, porém o hidrogel de HCA teve eficácia semelhante à dexametasona. Conclusão: Apesar de ainda ser necessário estudos para entender a toxicidade e segurança dos sistemas, nos testes in vivo em camundongos com dermatite psoriática induzida por imiquimode, a aplicação tópica do MTX pode ser uma nova abordagem para o tratamento da psoríase com menos efeitos colaterais e eficácia comprovada.application/pdfporUniversidade Federal de AlfenasPrograma de Pós-Graduação em Ciências FarmacêuticasUNIFAL-MGBrasilFaculdade de Ciências Farmacêuticasinfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/4.0/Cristais líquidosMetotrexatoHidrogéisCIENCIAS DA SAUDE::FARMACIADesenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríaseinfo:eu-repo/semantics/doctoralThesisinfo:eu-repo/semantics/publishedVersion-64258451559862442976006006997636413449754996reponame:Repositório Institucional da Universidade Federal de Alfenas - RiUnifalinstname:Universidade Federal de Alfenas (UNIFAL)instacron:UNIFALBernardes, Maria Tereza Carneiro PaschoalLICENSElicense.txtlicense.txttext/plain; charset=utf-81987https://repositorio.unifal-mg.edu.br/bitstreams/c2fcd399-98b2-423c-bd80-b771886f3f16/download31555718c4fc75849dd08f27935d4f6bMD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849https://repositorio.unifal-mg.edu.br/bitstreams/d2afa41a-f603-478b-bda4-fa823b755a1f/download4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-80https://repositorio.unifal-mg.edu.br/bitstreams/88b5c3a2-1073-4805-9e4f-d4c459047823/downloadd41d8cd98f00b204e9800998ecf8427eMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-80https://repositorio.unifal-mg.edu.br/bitstreams/930706b1-704d-4f6a-8c2d-45d7f3b2852d/downloadd41d8cd98f00b204e9800998ecf8427eMD54ORIGINALTese de Maria Tereza Carneiro Paschoal Bernardes.pdfTese de Maria Tereza Carneiro Paschoal Bernardes.pdfapplication/pdf2917784https://repositorio.unifal-mg.edu.br/bitstreams/149e65d7-3fca-48fb-a738-4851c798d397/download017f50508d618168b421fed6a54b3014MD55TEXTTese de Maria Tereza Carneiro Paschoal Bernardes.pdf.txtTese de Maria Tereza Carneiro Paschoal Bernardes.pdf.txtExtracted texttext/plain103251https://repositorio.unifal-mg.edu.br/bitstreams/a6122d00-4f43-4bc9-a19e-545bbb5a9ef8/download4314cf716b11b8ef58b64c6e425277b4MD58THUMBNAILTese de Maria Tereza Carneiro Paschoal Bernardes.pdf.jpgTese de Maria Tereza Carneiro Paschoal Bernardes.pdf.jpgGenerated Thumbnailimage/jpeg2580https://repositorio.unifal-mg.edu.br/bitstreams/b90da601-8c4a-433e-8d17-86dc54cd4b09/download6df2fb28d2506c9bf74471ede9dd0f83MD57123456789/17892026-01-07 14:42:38.011http://creativecommons.org/licenses/by-nc-nd/4.0/open.accessoai:repositorio.unifal-mg.edu.br:123456789/1789https://repositorio.unifal-mg.edu.brRepositório InstitucionalPUBhttps://bdtd.unifal-mg.edu.br:8443/oai/requestrepositorio@unifal-mg.edu.bropendoar:2026-01-07T17:42:38Repositório Institucional da Universidade Federal de Alfenas - RiUnifal - Universidade Federal de Alfenas (UNIFAL)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 |
| dc.title.pt-BR.fl_str_mv |
Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase |
| title |
Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase |
| spellingShingle |
Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase Bernardes, Maria Tereza Carneiro Paschoal Cristais líquidos Metotrexato Hidrogéis CIENCIAS DA SAUDE::FARMACIA |
| title_short |
Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase |
| title_full |
Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase |
| title_fullStr |
Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase |
| title_full_unstemmed |
Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase |
| title_sort |
Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase |
| author |
Bernardes, Maria Tereza Carneiro Paschoal |
| author_facet |
Bernardes, Maria Tereza Carneiro Paschoal |
| author_role |
author |
| dc.contributor.author.fl_str_mv |
Bernardes, Maria Tereza Carneiro Paschoal |
| dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/3119063906096827 |
| dc.contributor.advisor-co1.fl_str_mv |
Novaes, Rômulo Dias |
| dc.contributor.referee1.fl_str_mv |
Santos, Bruno Da Fonseca Dos |
| dc.contributor.referee2.fl_str_mv |
Santos, Aline Martins Dos |
| dc.contributor.referee3.fl_str_mv |
Neves, Juliana Dos Santos |
| dc.contributor.referee4.fl_str_mv |
Trevisan , Marcello Garcia |
| dc.contributor.advisor1.fl_str_mv |
Carvalho, Flávia Chiva |
| dc.contributor.authorLattes.fl_str_mv |
http://lattes.cnpq.br/4208266173100826 |
| contributor_str_mv |
Novaes, Rômulo Dias Santos, Bruno Da Fonseca Dos Santos, Aline Martins Dos Neves, Juliana Dos Santos Trevisan , Marcello Garcia Carvalho, Flávia Chiva |
| dc.subject.por.fl_str_mv |
Cristais líquidos Metotrexato Hidrogéis |
| topic |
Cristais líquidos Metotrexato Hidrogéis CIENCIAS DA SAUDE::FARMACIA |
| dc.subject.cnpq.fl_str_mv |
CIENCIAS DA SAUDE::FARMACIA |
| description |
Introduction: Psoriasis is an autoimmune, inflammatory and chronic skin disease in which there is an acceleration of cell growth and proliferation, resulting in erythema and ill-defined lesions, with white and red stains and peeling of the epidermis. Methotrexate (MTX) is one of the drugs for the treatment of systemic use, but there are several side effects. Topical administration may be a strategy to vectorize the release of this drug at the site of action, but as the stratum corneum epidermis is a permeation barrier for hydrophilic drugs, it is necessary to develop vehicles that promote its penetration into the skin. Objective: To evaluate the topical effect of MTX in psoriasis using liquid- crystalline systems (CLs) and hydrogels as vehicles. Method: Study of phase behavior by constructing the ternary phase diagram combining polysorbate 80 (Tween® 80), isopropyl myristate (MIP) and MiliQ water to obtain CLs. The hydrogels tested were based on chitosan (HQS), hydroxypropylmethylcellulose phthalate (HHPMC) and alkylated carbomer (HCA). The samples were characterized by polarized light microscopy (MLP), oscillatory rheology, texture analysis (TPA), solubility of MTX, obtaining the release profile, ex vivo bioadhesion studies and in vivo tests in mice with induction of psoriatic dermatitis. Results: Systems containing surfactant / oil / water in the proportions 60/10/30 and 60/20/20 were characterized as lamellar phases (L1 and L2, respectively) and 50/10/40 and 50/20/30 as hexagonal phases ( H1 and H2, respectively). It was possible to solubilize MTX at a concentration of 2 mg / mL in the CLs and in the HCA hydrogel (pH = 7.4), and 0.1 mg / mL in the HQS hydrogel (pH = 3.5) and not solubilized in HPMCP ( pH = 4.5). Oscillatory rheology showed that hexagonal phases are more elastic than lamellar phases, and HCA with behavior similar to lamellar phases. The TPA test correlated with rheology, but ex vivo bioadhesion showed a better interaction of HCA with swine skin in relation to CLs. The release profile showed that H1 and H2 retained MTX more than L1 and L2, due to their more rigid and organized structure. HCA released more MTX showing that the gelled polymer network retains the drug less. The release profile adjusted for the Weibull mathematical model indicated that the release kinetics is fast and complex. As a proof of principle, in vivo tests showed that CLs promoted a more exacerbated inflammatory effect, but the HCA hydrogel had similar efficacy to dexamethasone. Conclusion: Although studies are still needed to understand the toxicity and safety of the systems, in in vivo tests in mice with imiquimod-induced psoriatic dermatitis, topical application of MTX may be a new approach for the treatment of psoriasis with less side effects and proven efficacy. |
| publishDate |
2021 |
| dc.date.accessioned.fl_str_mv |
2021-03-31T18:05:03Z |
| dc.date.issued.fl_str_mv |
2021-02-22 |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/doctoralThesis |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
doctoralThesis |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
BERNARDES, Maria Tereza Carneiro Paschoal. Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase. 2021. 126 f. Tese ( Doutorado em Ciências Farmacêuticas) - Universidade Federal de Alfenas, Alfenas, MG, 2021. |
| dc.identifier.uri.fl_str_mv |
https://repositorio.unifal-mg.edu.br/handle/123456789/1789 |
| identifier_str_mv |
BERNARDES, Maria Tereza Carneiro Paschoal. Desenvolvimento de cristais líquidos e hidrogéis para administração cutânea de metotrexato para tratamento de psoríase. 2021. 126 f. Tese ( Doutorado em Ciências Farmacêuticas) - Universidade Federal de Alfenas, Alfenas, MG, 2021. |
| url |
https://repositorio.unifal-mg.edu.br/handle/123456789/1789 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.relation.department.fl_str_mv |
-6425845155986244297 |
| dc.relation.confidence.fl_str_mv |
600 600 |
| dc.relation.cnpq.fl_str_mv |
6997636413449754996 |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Universidade Federal de Alfenas |
| dc.publisher.program.fl_str_mv |
Programa de Pós-Graduação em Ciências Farmacêuticas |
| dc.publisher.initials.fl_str_mv |
UNIFAL-MG |
| dc.publisher.country.fl_str_mv |
Brasil |
| dc.publisher.department.fl_str_mv |
Faculdade de Ciências Farmacêuticas |
| publisher.none.fl_str_mv |
Universidade Federal de Alfenas |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da Universidade Federal de Alfenas - RiUnifal instname:Universidade Federal de Alfenas (UNIFAL) instacron:UNIFAL |
| instname_str |
Universidade Federal de Alfenas (UNIFAL) |
| instacron_str |
UNIFAL |
| institution |
UNIFAL |
| reponame_str |
Repositório Institucional da Universidade Federal de Alfenas - RiUnifal |
| collection |
Repositório Institucional da Universidade Federal de Alfenas - RiUnifal |
| bitstream.url.fl_str_mv |
https://repositorio.unifal-mg.edu.br/bitstreams/c2fcd399-98b2-423c-bd80-b771886f3f16/download https://repositorio.unifal-mg.edu.br/bitstreams/d2afa41a-f603-478b-bda4-fa823b755a1f/download https://repositorio.unifal-mg.edu.br/bitstreams/88b5c3a2-1073-4805-9e4f-d4c459047823/download https://repositorio.unifal-mg.edu.br/bitstreams/930706b1-704d-4f6a-8c2d-45d7f3b2852d/download https://repositorio.unifal-mg.edu.br/bitstreams/149e65d7-3fca-48fb-a738-4851c798d397/download https://repositorio.unifal-mg.edu.br/bitstreams/a6122d00-4f43-4bc9-a19e-545bbb5a9ef8/download https://repositorio.unifal-mg.edu.br/bitstreams/b90da601-8c4a-433e-8d17-86dc54cd4b09/download |
| bitstream.checksum.fl_str_mv |
31555718c4fc75849dd08f27935d4f6b 4afdbb8c545fd630ea7db775da747b2f d41d8cd98f00b204e9800998ecf8427e d41d8cd98f00b204e9800998ecf8427e 017f50508d618168b421fed6a54b3014 4314cf716b11b8ef58b64c6e425277b4 6df2fb28d2506c9bf74471ede9dd0f83 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da Universidade Federal de Alfenas - RiUnifal - Universidade Federal de Alfenas (UNIFAL) |
| repository.mail.fl_str_mv |
repositorio@unifal-mg.edu.br |
| _version_ |
1859830899930038272 |